Gene expression profiling of Philadelphia chromosome (Ph)-negative CD34+ hematopoietic stem and progenitor cells of patients with Ph-positive CML in major molecular remission during therapy with imatinib.
Please log in to take part in the discussion (add own reviews or comments).
Cite this publication
More citation styles
- please select -
%0 Journal Article
%1 Neumann2005
%A Neumann, F.
%A Teutsch, N.
%A Kliszewski, S.
%A Bork, S.
%A Steidl, U.
%A Brors, B.
%A Schimkus, N.
%A Roes, N.
%A Germing, U.
%A Hildebrandt, B.
%A Royer-Pokora, B.
%A Eils, R.
%A Gattermann, N.
%A Haas, R.
%A Kronenwett, R.
%D 2005
%J Leukemia
%K /&/ Adult; Aged; Antigens, BCR-ABL Benzamides; CD34, Cells, Chromosome; Chronic, Chronic-Phase, Expression Female; Fusion Gene Hematopoietic Humans; Induction, Kinases, Leukemia, Male; Middle Myelogenous, Myeloid, Philadelphia Phylogeny; Piperazines, Positive, Profiling; Protein-Tyrosine Proteins, Pyrimidines, Remission Stem antagonists bcr-abl, biosynthesis/genetics/immunology; drug genetics; immunology/metabolism; inhibitors; methods therapeutic therapy/genetics/immunology; therapy/genetics; use;
%N 3
%P 458--460
%R 10.1038/sj.leu.2403615
%T Gene expression profiling of Philadelphia chromosome (Ph)-negative CD34+ hematopoietic stem and progenitor cells of patients with Ph-positive CML in major molecular remission during therapy with imatinib.
%U http://dx.doi.org/10.1038/sj.leu.2403615
%V 19
@article{Neumann2005,
__markedentry = {[bbrors:6]},
added-at = {2015-04-09T12:36:21.000+0200},
author = {Neumann, F. and Teutsch, N. and Kliszewski, S. and Bork, S. and Steidl, U. and Brors, B. and Schimkus, N. and Roes, N. and Germing, U. and Hildebrandt, B. and Royer-Pokora, B. and Eils, R. and Gattermann, N. and Haas, R. and Kronenwett, R.},
biburl = {https://www.bibsonomy.org/bibtex/289540f80867cb753d207bcad2bc74295/bbrors},
doi = {10.1038/sj.leu.2403615},
interhash = {b3fc60f09503f8eca08bfd6ede2a3430},
intrahash = {89540f80867cb753d207bcad2bc74295},
journal = {Leukemia},
keywords = {/&/ Adult; Aged; Antigens, BCR-ABL Benzamides; CD34, Cells, Chromosome; Chronic, Chronic-Phase, Expression Female; Fusion Gene Hematopoietic Humans; Induction, Kinases, Leukemia, Male; Middle Myelogenous, Myeloid, Philadelphia Phylogeny; Piperazines, Positive, Profiling; Protein-Tyrosine Proteins, Pyrimidines, Remission Stem antagonists bcr-abl, biosynthesis/genetics/immunology; drug genetics; immunology/metabolism; inhibitors; methods therapeutic therapy/genetics/immunology; therapy/genetics; use;},
language = {eng},
medline-pst = {ppublish},
month = Mar,
number = 3,
owner = {bbrors},
pages = {458--460},
pii = {2403615},
pmid = {15618956},
timestamp = {2015-04-09T12:36:21.000+0200},
title = {Gene expression profiling of Philadelphia chromosome (Ph)-negative CD34+ hematopoietic stem and progenitor cells of patients with Ph-positive CML in major molecular remission during therapy with imatinib.},
url = {http://dx.doi.org/10.1038/sj.leu.2403615},
volume = 19,
year = 2005
}